SpyGlass Pharma Inc. Common Stock

SGP | NASDAQ

$33.15

+$0.91 (+2.82%)

Nov 2, 2026, 9:57 AM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025
Cash & Equivalents	223.14M	238.9M	96.36M	106.01M
Short-Term Investments	11.04M	12.1M	11.08M	12.03M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	759K	789K	3.21M	2.19M
Receivables	678K	653K	431K	418.01K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.6M	1.71M	n/a	10.42K
Total Current Assets	236.46M	253.36M	108.77M	119.7M
Property-Plant & Equipment	6.21M	4.24M	3.89M	5.13M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.97M	5.02M	7.1M	7.32M
Total Assets	243.43M	258.39M	115.87M	127.01M
Account Payables	4.16M	3.51M	2.7M	1.68M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	3.56M	2.27M	5.89M	4.45M
Total Current Liabilities	9.44M	6.67M	8.58M	6.61M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	204.54M	204.54M
Total Long-Term Liabilities	1.63M	1.61M	206.12M	207.63M
Total Liabilities	11.07M	8.27M	214.7M	214.24M
Total Debt	1.63M	1.61M	1.58M	3.57M
Book Value	232.36M	250.11M	-98.84M	-87.22M
Book Value Per Share	6.95	12.55	-2.96	-2.61
Common Stock	n/a	n/a	n/a	41
Retained Earnings	-138.41M	-118.55M	-104.73M	-92.18M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	232.36M	250.11M	-98.84M	-87.22M
Total Investments	11.04M	12.1M	11.08M	12.03M